Articles From: Titan Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference to RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis


http://media.marketwire.com/attachments/201106/27974_TITANlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141683&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Titan Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference investment picks
Today, Groupon ( http://www.groupon.com ) (NASDAQ: GRPN) announced a new time-based deals option for all local businesses that accept reservations or take appointments, enabling them to control exactly when customers come into their business.
Sign-up for Groupon Unveils Time-Based Deals for All Local Businesses that Accept Reservations or Take Appointments investment picks
Garmin International Inc., a unit of Garmin Ltd.
Sign-up for New Garmin® nüvi® Advanced Series Features Foursquare® Data, Large Multi-Touch Displays investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020564-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/26/11G020564/GI_logo_SINGLE_COLOR-1173897809046.jpg LOUISVILLE, CO--(Marketwired - September 03, 2014) - GlobeImmune, Inc. (NASDAQ: GBIM) today announced that Timothy C.
Sign-up for GlobeImmune to Present at the Aegis Capital Corp. 2014 Healthcare Conference investment picks
Alkermes plc (NASDAQ: ALKS) today announced completion of patient enrollment in a phase 2 study of ALKS 3831, an investigational, novel, oral, broad-spectrum atypical antipsychotic medicine in development for the treatment of schizophrenia.
Sign-up for Alkermes Announces Completion of Patient Enrollment in Phase 2 Study of ALKS 3831, a Novel, Broad-Spectrum Oral Antipsychotic investment picks
CBS Outdoor Americas Inc. (NYSE:CBSO) announced today that Jeremy Male, Chief Executive Officer, is scheduled to present at the Goldman Sachs 23 rd Annual Communacopia Conference in New York, New York on Wednesday, September 10, 2014 at 2:55 p.m. Eastern Time.
Sign-up for CBS Outdoor Chief Executive Officer Jeremy Male to Participate in the Goldman Sachs Communacopia Conference investment picks
2014/9/3
ST. LOUIS, Sept.
Sign-up for Research From Equifax Workforce Solutions Explores Onboarding Best Practices for Higher Education investment picks
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer.
Sign-up for NeuroMetrix Names Senior Executive to Lead Consumer Healthcare Initiative Frank McGillin - SVP and GM, Consumer investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.
Sign-up for Antares Pharma to Participate at the Morgan Stanley Healthcare Conference investment picks
Delivering Industry-leading 250fs Jitter in an Ultra-small 5x5 mm Footprint, Devices are Ideal for a Variety of Communications Applications ALISO VIEJO, Calif.
Sign-up for Microsemi Strengthens its Timing Products Leadership with New Any-to-any Frequency Clock Multiplier and Jitter Attenuator Clock Management Products investment picks
F5 Networks (NASDAQ: FFIV ) today introduced new Software Defined Application Services ™ (SDAS ™ ) for its physical and virtual BIG-IP ® solutions, extending the company’s access, security, and acceleration technologies for the highest levels of scale and performance.
Sign-up for F5 Introduces Next Wave of Software Defined Application Services investment picks
PETACH TIKVA, Israel , Sept.
Sign-up for Can-Fite to Present at Rodman & Renshaw Global Investment Conference in New York City on September 9, 2014 investment picks
eBay, ChannelAdvisor veteran charged with deepening RetailMeNot's relationships with the largest retailers and brands AUSTIN, Texas , Sept.
Sign-up for RetailMeNot, Inc. Names Michael Jones as Senior Vice President, Retailer and Brand Solutions investment picks
Ranking Based on User Ratings and Market Segment Adoption RESTON, Va.
Sign-up for comScore Rated Strong Performer in TrustRadius Digital Analytics TrustMap™ for Enterprises investment picks
Avnet Electronics Marketing , an operating group of Avnet, Inc .
Sign-up for Avnet Electronics Marketing Releases PicoZed System-On-Module investment picks
Coca-Cola Enterprises (NYSE: CCE)(Euronext Paris: CCE) will discuss its plans and outlook with investors today at the Barclays Back-to-School Consumer Conference in Boston at 2:15 p.m. ET.
Sign-up for CCE Presents at Barclays Back-to-School Investor Conference, Provides Full-Year 2014 Guidance investment picks
2014/9/3
Concordia Healthcare Announces Agreement to Acquire Zonegran® in the United States and Puerto Rico Canada NewsWire "The acquisition of Zonegran for commercialization in the United States and Puerto Rico represents another advancement in the execution of Concordia's legacy product strategy, which management believes will provide significant and sustainable revenue going forward," said Mark Thompson , CEO of Concordia .
Sign-up for Concordia Healthcare Announces Agreement to Acquire Zonegran® in the United States and Puerto Rico investment picks
2014/9/3
Couche-Tard Sells its Aviation Fuel Business Canada NewsWire About Alimentation Couche-Tard Inc. Couche-Tard is the leader in the Canadian convenience store industry.
Sign-up for Couche-Tard Sells its Aviation Fuel Business investment picks
2014/9/3
LAVAL, QC , Sept.
Sign-up for Couche-Tard Sells its Aviation Fuel Business investment picks
Gupta Technologies , a global provider of application development, database and migration software, today announced a successful deployment of a mobile application using TD Mobile by the Friends of Israel (FOI) organization.
Sign-up for Gupta Technologies’ TD Mobile Enables Non-profit Organization, Friends of Israel, Access to Critical Data from Mobile Devices While in the Field investment picks
Redknee Signs $6 Million Dollar Order with Tier 1 APAC Operator Canada NewsWire TORONTO , Sept.
Sign-up for Redknee Signs $6 Million Dollar Order with Tier 1 APAC Operator investment picks
Kohl’s Department Stores (NYSE: KSS) and AwesomenessTV today announced a partnership to launch S.o. R.a.d., a seven capsule limited-edition junior’s fashion line and Life’s S.o. R.a.d. , an original four season YouTube series featuring top teen influencers.
Sign-up for Kohl’s Department Stores Partners with AwesomenessTV on Breakthrough New Fashion Line and Original YouTube Series investment picks
First molecular test indicated for samples from both males and females SUNNYVALE, Calif.
Sign-up for Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020932-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/2/11G020932/logo-1384140982526.jpg BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - September 03, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F.
Sign-up for Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference investment picks
Cipher Pharmaceuticals Inc. to present at Rodman & Renshaw 16th Annual Global Investment Conference Canada NewsWire MISSISSAUGA, ON , Sept.
Sign-up for Cipher Pharmaceuticals Inc. to present at Rodman & Renshaw 16th Annual Global Investment Conference investment picks
http://media.marketwire.com/attachments/201402/227789_CBLI_logo2012.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141649&ProfileId=051205&sourceType=1 BUFFALO, NY --
Sign-up for Cleveland BioLabs Announces Green Light to Submit Pre-Emergency Use Authorization Application for Entolimod investment picks
The randomized, double-blind, placebo-controlled, parallel group Phase III study with RHB-102 (the GUARD study) will enroll 320 acute gastroenteritis patients in the U.S. Acute gastroenteritis is an inflammation of the gastrointestinal tract causing nausea and vomiting, with a potential worldwide market estimated to exceed $650 million If approved for marketing by the FDA, RHB-102 is expected to be the first-ever 5-HT3 antagonist drug indicated for acute gastroenteritis Dr.
Sign-up for RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Titan Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference to RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices